136 related articles for article (PubMed ID: 37752126)
1. Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group.
Mironova D; Saraswati CM; Downie P; Lai CY; Cook E; Carruthers V; Moukhaiber P; Molloy F; Serov J; McKinnon E; Alvaro F; Osborn M; Revesz T; Prestidge T; Cross S; Bateman CM; Moore AS; Khaw SL; Mateos MK; Kotecha RS
Blood Cancer J; 2023 Sep; 13(1):150. PubMed ID: 37752126
[No Abstract] [Full Text] [Related]
2. Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group.
Moore AS; Shaw PJ; Hallahan AR; Carter TL; Kilo T; Nivison-Smith I; O'Brien TA; Tapp H; Teague L; Wilson SR; Tiedemann K
Med J Aust; 2009 Feb; 190(3):121-5. PubMed ID: 19203307
[TBL] [Abstract][Full Text] [Related]
3. Are outcomes for childhood leukaemia in Australia influenced by geographical remoteness and Indigenous race?
Jessop S; Ruhayel S; Sutton R; Youlden DR; Pearson G; Lu C; Milne S; Henderson MJ; Aitken JF; Kotecha RS; Revesz T
Pediatr Blood Cancer; 2021 Apr; 68(4):e28945. PubMed ID: 33565233
[TBL] [Abstract][Full Text] [Related]
4. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
[TBL] [Abstract][Full Text] [Related]
5. Treatment-related mortality in children with acute lymphoblastic leukaemia in a low-middle income country.
; Faizan M; Shamim W
J Pak Med Assoc; 2021 Oct; 71(10):2373-2377. PubMed ID: 34974574
[TBL] [Abstract][Full Text] [Related]
6. Vitamin and mineral supplements in pregnancy and the risk of childhood acute lymphoblastic leukaemia: a case-control study.
Dockerty JD; Herbison P; Skegg DC; Elwood M
BMC Public Health; 2007 Jul; 7():136. PubMed ID: 17605825
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of leukaemia in paediatric haematology day hospital].
Héritier S; Morand K; Courcoux MF; Leverger G
Soins Pediatr Pueric; 2015; (285):17-21. PubMed ID: 26183094
[TBL] [Abstract][Full Text] [Related]
8. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
[TBL] [Abstract][Full Text] [Related]
9. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
[TBL] [Abstract][Full Text] [Related]
10. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
11. Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK.
Feltbower RG; Moorman AV; Dovey G; Kinsey SE; McKinney PA
Lancet; 2001 Aug; 358(9279):385-7. PubMed ID: 11502322
[TBL] [Abstract][Full Text] [Related]
12. Incidence of childhood precursor B-cell acute lymphoblastic leukaemia in north-west England.
McNally RJ; Birch JM; Taylor GM; Eden OB
Lancet; 2000 Aug; 356(9228):485-6. PubMed ID: 10981897
[TBL] [Abstract][Full Text] [Related]
13. Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
Blair CK; Roesler M; Xie Y; Gamis AS; Olshan AF; Heerema NA; Robison LL; Ross JA;
Paediatr Perinat Epidemiol; 2008 May; 22(3):288-95. PubMed ID: 18426524
[TBL] [Abstract][Full Text] [Related]
14. The experience of a single Australian paediatric oncology unit. 1000 patients 1964-1987.
McCowage GB; Vowels MR; Brown R; O'Gorman-Hughes D; White L; Marshall G
Med J Aust; 1993 Oct; 159(7):453-5, 458. PubMed ID: 8412916
[TBL] [Abstract][Full Text] [Related]
15. Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort study.
Ishida Y; Maeda M; Urayama KY; Kiyotani C; Aoki Y; Kato Y; Goto S; Sakaguchi S; Sugita K; Tokuyama M; Nakadate N; Ishii E; Tsuchida M; Ohara A;
Br J Haematol; 2014 Jan; 164(1):101-12. PubMed ID: 24116892
[TBL] [Abstract][Full Text] [Related]
16. Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia.
Howell DL; Lew G; Comeaux LG; Meacham LR
Pediatr Blood Cancer; 2007 Sep; 49(3):349-52. PubMed ID: 16602119
[TBL] [Abstract][Full Text] [Related]
17. Progress towards a cure for acute lymphoblastic leukaemia in Morocco.
Ghazi B; Elghanmi A; Bouanani N; Maryame A; Nejjari C
East Mediterr Health J; 2023 Aug; 29(8):605-607. PubMed ID: 37698215
[No Abstract] [Full Text] [Related]
18. Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.
Weinkove R; McQuilten ZK; Adler J; Agar MR; Blyth E; Cheng AC; Conyers R; Haeusler GM; Hardie C; Jackson C; Lane SW; Middlemiss T; Mollee P; Mulligan SP; Ritchie D; Ruka M; Solomon B; Szer J; Thursky KA; Wood EM; Worth LJ; Yong MK; Slavin MA; Teh BW
Med J Aust; 2020 Jun; 212(10):481-489. PubMed ID: 32401360
[TBL] [Abstract][Full Text] [Related]
19. Adaptive functioning and academic achievement in survivors of childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Jacola LM; Baran J; Noll RB; Willard VW; Hardy KK; Embry L; Hullmann SE; Larsen EC; Winick N; Kairalla JA
Pediatr Blood Cancer; 2021 Apr; 68(4):e28913. PubMed ID: 33522102
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statement.
Furlong E; Kotecha RS; Conyers R; O'Brien TA; Hansford JR; Super L; Downie P; Eisenstat DD; Haeusler G; McMullan B; Phillips MB; Padhye B; Dalla-Pozza L; Alvaro F; Fraser CJ; Nicholls W; Clark JE; O'Connor M; Saxon BR; Tapp H; Heath J; Hunter SE; Tsui K; Winstanley M; Lyver A; Best EJ; Wadia U; Yeoh D; Blyth CC; Gottardo NG
Med J Aust; 2022 Apr; 216(6):312-319. PubMed ID: 35201615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
